Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 325

1.

C-kit expression of melanocytic neoplasm and association with clinicopathological parameters and anatomic locations in Chinese people.

Lin YC, Chang YM, Ho JY, Lin HC, Tsai YM, Chiang CP, Wang WM, Gao HW.

Am J Dermatopathol. 2013 Jul;35(5):569-75. doi: 10.1097/DAD.0b013e318279566a.

PMID:
23221472
2.

Fascin, cortactin and survivin expression of melanocytic neoplasms and association with clinicopathological parameters and anatomic locations in Chinese people.

Gao HW, Yu CP, Lee HS, Nieh S, Chiang CP, Wang WM, Jin JS.

Eur J Dermatol. 2010 May-Jun;20(3):293-301. doi: 10.1684/ejd.2010.0927. Epub 2010 Apr 16.

PMID:
20400386
3.

Lack of correlation between immunohistochemical expression of CKIT and KIT mutations in atypical acral nevi.

Park E, Yang S, Emley A, DeCarlo K, Richards J, Mahalingam M.

Am J Dermatopathol. 2012 Feb;34(1):41-6. doi: 10.1097/DAD.0b013e31821ec0ef.

PMID:
22094233
4.

Mast cells in melanocytic skin lesions. An immunohistochemical and quantitative study.

Dyduch G, Okoń K, Pescarini E.

Pol J Pathol. 2011 Sep;62(3):139-44.

5.

Analysis of KIT expression and gene mutation in human acral melanoma: with a comparison between primary tumors and corresponding metastases/recurrences.

Dai B, Cai X, Kong YY, Yang F, Shen XX, Wang LW, Kong JC.

Hum Pathol. 2013 Aug;44(8):1472-8. doi: 10.1016/j.humpath.2013.01.007. Epub 2013 Mar 22.

PMID:
23528861
6.

KIT amplification and gene mutations in acral/mucosal melanoma in Korea.

Yun J, Lee J, Jang J, Lee EJ, Jang KT, Kim JH, Kim KM.

APMIS. 2011 Jun;119(6):330-5. doi: 10.1111/j.1600-0463.2011.02737.x. Epub 2011 Mar 24.

PMID:
21569090
7.

Prognostic significance of cytoplasmic p27 expression in human melanoma.

Chen G, Cheng Y, Zhang Z, Martinka M, Li G.

Cancer Epidemiol Biomarkers Prev. 2011 Oct;20(10):2212-21. doi: 10.1158/1055-9965.EPI-11-0472. Epub 2011 Aug 9.

8.

C-Kit SCF receptor (CD117) expression and KIT gene mutation in conjunctival pigmented lesions.

Alessandrini L, Parrozzani R, Bertorelle R, Valentini E, Candiotto C, Giacomelli L, Midena E, Blandamura S.

Acta Ophthalmol. 2013 Dec;91(8):e641-5. doi: 10.1111/aos.12166. Epub 2013 Jun 7.

9.
10.
11.

Large-scale analysis of KIT aberrations in Chinese patients with melanoma.

Kong Y, Si L, Zhu Y, Xu X, Corless CL, Flaherty KT, Li L, Li H, Sheng X, Cui C, Chi Z, Li S, Han M, Mao L, Lu A, Guo J.

Clin Cancer Res. 2011 Apr 1;17(7):1684-91. doi: 10.1158/1078-0432.CCR-10-2346. Epub 2011 Feb 15.

12.

Immunohistochemical expression patterns of the microRNA-processing enzyme Dicer in cutaneous malignant melanomas, benign melanocytic nevi and dysplastic melanocytic nevi.

Sand M, Gambichler T, Sand D, Altmeyer P, Stuecker M, Bechara FG.

Eur J Dermatol. 2011 Jan-Feb;21(1):18-21. doi: 10.1684/ejd.2011.1210.

PMID:
21262599
13.

Predictors of BRAF mutation in melanocytic nevi: analysis across regions with different UV radiation exposure.

Karram S, Novy M, Saroufim M, Loya A, Taraif S, Houreih MA, Rauscher B, Habib RH, Oberkanins C, Khalifeh I.

Am J Dermatopathol. 2013 Jun;35(4):412-8. doi: 10.1097/DAD.0b013e31826db181.

PMID:
23051629
14.

Mutation analysis of the EGFR-NRAS-BRAF pathway in melanomas from black Africans and other subgroups of cutaneous melanoma.

Akslen LA, Puntervoll H, Bachmann IM, Straume O, Vuhahula E, Kumar R, Molven A.

Melanoma Res. 2008 Feb;18(1):29-35. doi: 10.1097/CMR.0b013e3282f32517.

PMID:
18227705
15.

Inducible nitric oxide synthase expression in benign and malignant cutaneous melanocytic lesions.

Massi D, Franchi A, Sardi I, Magnelli L, Paglierani M, Borgognoni L, Maria Reali U, Santucci M.

J Pathol. 2001 Jun;194(2):194-200.

PMID:
11400148
16.

KIT genetic alterations in anorectal melanomas.

Santi R, Simi L, Fucci R, Paglierani M, Pepi M, Pinzani P, Merelli B, Santucci M, Botti G, Urso C, Massi D.

J Clin Pathol. 2015 Feb;68(2):130-4. doi: 10.1136/jclinpath-2014-202572. Epub 2014 Nov 14.

PMID:
25398993
17.

Different patterns of expression of the erbB family of receptor tyrosine kinases in common nevi, dysplastic nevi, and primary malignant melanomas: an immunohistochemical study.

Feinmesser M, Veltman V, Morgenstern S, Tobar A, Gutman H, Kaganovsky E, Tzabari C, Sulkes J, Okon E.

Am J Dermatopathol. 2010 Oct;32(7):665-75. doi: 10.1097/DAD.0b013e3181d1e6f0.

PMID:
20559114
18.

Benign melanocytic lesions: risk markers or precursors of cutaneous melanoma?

Skender-Kalnenas TM, English DR, Heenan PJ.

J Am Acad Dermatol. 1995 Dec;33(6):1000-7.

PMID:
7490345
19.
20.

c-kit gene mutation and CD117 expression in human anorectal melanomas.

Ni S, Huang D, Chen X, Huang J, Kong Y, Xu Y, Du X, Sheng W.

Hum Pathol. 2012 Jun;43(6):801-7. doi: 10.1016/j.humpath.2011.08.005. Epub 2011 Dec 9.

PMID:
22154054

Supplemental Content

Support Center